Achieve Life Sciences
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -57 | -54 | -55 | -62 |
EBITDA | -14,674 | -14,194 | -12,472 | -12,580 |
EBIT | -14,731 | -14,249 | -12,527 | -12,642 |
Net Income | -14,662 | -14,441 | -12,718 | -12,827 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -17,980 | -11,331 | -9,069 | -11,088 |
Cash | 20,929 | 31,930 | 51,874 | 13,016 |
Basic Shares | 53,276 | 51,017 | 34,685 | 34,685 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -228 | -229 | -228 | -236 |
EBITDA | -54,652 | -37,418 | -26,734 | -40,564 |
EBIT | -54,880 | -37,647 | -26,962 | -40,800 |
Net Income | -54,648 | -39,827 | -29,815 | -41,875 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -18,254 | |||
Free Cash Flow | -49,468 | -29,770 | -24,500 | -37,569 |
Cash | 20,929 | 12,733 | 15,546 | 24,721 |
Basic Shares | 43,594 | 32,071 | 19,827 | 10,593 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$0.28 |
2025-09-30 | -$0.28 |
2025-06-30 | -$0.37 |
2025-03-31 | -$0.37 |
